Synageva BioPharma and Trimeris Announce Filing of S-4 Registration Statement Regarding the Previously Announced Merger

Synageva BioPharma Corp. and Trimeris, Inc. TRMS announced today that Trimeris has filed a Form S-4 Registration Statement with the U.S. Securities and Exchange Commission pertaining to the previously announced merger of Trimeris and Synageva. The Registration Statement has not yet been declared effective, and the information contained therein is subject to change. Once the Registration Statement has been declared effective, Synageva and Trimeris intend to set a date for a special meeting of each of their respective stockholders to approve the merger and deliver the final joint proxy statement/prospectus to their respective stockholders.